Another notable valuation metric for PBH is its P/B ratio of 2.28. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total ...

PBH currently has a forward P/E ratio of 17.73, while SYK has a forward P/E of 28.63. We also note that PBH has a PEG ratio of 2.53. This popular figure is similar to the widely-used P/E ratio, ...

We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other stocks that ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

When a caller asked about Stryker Corporation (NYSE:SYK), Cramer replied: “I like Stryker, but you know, I don’t like it enough. I don’t like it as much as if it was Intuitive Surgical.

Mark Brooke hopes the program will signal a new era of hope for lung cancer patients. (ABC News: Lucas Hill)The screening program will offer a bulk-billed low-dose CT scan for the 930,000 people ...

Get Instant Summarized Text (Gist) A lipid nanoparticle system was developed to deliver DNase I and Sivelestat directly to lung neutrophils in a COVID-19 mouse model.

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer who received an immunotherapy drug, nivolumab, along with standard ...

Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments. Skip to main content. Your source for the latest research news.